Attralus

Developer of drugs for the treatment of Amyloid diseases

placeSan Francisco, California, United States calendar_todayFounded 2019 groups23 employees language attralus.com

Registered entities

Social engagement

Social engagement: 2.4K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

16 investors on record; lead investors include VenBio, Logos, Alpha Wave Global.

Investor typeCountShare
Venture capital531%
Private equity319%
Accelerator & incubator213%
Bank & private debt16%
Other / undisclosed531%
Coming soon